Literature DB >> 347462

Historical view on ergot alkaloids.

A Hofmann.   

Abstract

A short survey of the history of ergot, of the original and, for a long time, only source of ergot alkaloids, is given. Once a dreaded poison, ergot has changed its role over the centuries to become a rich treasure house of valuable pharmaceuticals. In the Middle Ages it was the cause of epidemics of ergotism, which cost tens of thousands of people their lives. Ergot was first mentioned by the German physician Lonitzer in 1582 as a remedy used by midwives for quickening childbirth. The isolation of pharmacologically useful alkaloids started in 1906 with the discovery of ergotoxine and its adrenolytic activity by Barger, Carr and Dale. In 1918, Stoll isolated ergotamine, the first chemically pure ergot alkaloid, which found widespread therapeutic use in obstetrics and internal medicine. In 1935 the specific oxytocic principle of ergot, ergonovine, was discovered simultaneously in four separate laboratories. Since then, worldwide investigations on ergot alkaloids resulted in the elucidation of their structures and total syntheses and preparation of valuable therapeutics such as Methergine, Hydergine, Dihydergot, and others.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 347462     DOI: 10.1159/000136803

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  8 in total

Review 1.  Structure and function of serotonin G protein-coupled receptors.

Authors:  John D McCorvy; Bryan L Roth
Journal:  Pharmacol Ther       Date:  2015-01-17       Impact factor: 12.310

2.  Retrospective and Prospective Look at Aflatoxin Research and Development from a Practical Standpoint.

Authors:  Noreddine Benkerroum
Journal:  Int J Environ Res Public Health       Date:  2019-09-27       Impact factor: 3.390

3.  Coalescing beneficial host and deleterious antiparasitic actions as an antischistosomal strategy.

Authors:  John D Chan; Timothy A Day; Jonathan S Marchant
Journal:  Elife       Date:  2018-07-30       Impact factor: 8.140

4.  Cleaving Ergot Alkaloids by Hydrazinolysis-A Promising Approach for a Sum Parameter Screening Method.

Authors:  Maximilian Kuner; Susanne Kühn; Hajo Haase; Klas Meyer; Matthias Koch
Journal:  Toxins (Basel)       Date:  2021-05-11       Impact factor: 4.546

5.  Crystal structure of rac-3-[2,3-bis-(phenyl-sulfan-yl)-3H-indol-3-yl]propanoic acid.

Authors:  Wayland E Noland; Christopher D Brown; Amanda M Bisel; Andrew K Schneerer; Kenneth J Tritch
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-10-31

6.  Arterial Responses to Acute Low-Level Ergot Exposure in Hereford Cows.

Authors:  Vanessa Elizabeth Cowan; Alex Neumann; John McKinnon; Barry Raymond Blakley; Taylor Jayne Grusie; Jaswant Singh
Journal:  Front Vet Sci       Date:  2018-10-16

7.  Diversification of ergot alkaloids and heritable fungal symbionts in morning glories.

Authors:  Wesley T Beaulieu; Daniel G Panaccione; Quynh N Quach; Katy L Smoot; Keith Clay
Journal:  Commun Biol       Date:  2021-12-06

Review 8.  The Usage of Ergot (Claviceps purpurea (fr.) Tul.) in Obstetrics and Gynecology: A Historical Perspective.

Authors:  Aleksander Smakosz; Wiktoria Kurzyna; Michał Rudko; Mateusz Dąsal
Journal:  Toxins (Basel)       Date:  2021-07-15       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.